Low-dose computed tomography (LDCT) versus other cancer screenings in early diagnosis of lung cancer: A meta-analysis

por Wang, Xiaojing, Liu, Hongli, Shen, Yuanbing, Li, Wei, Chen, Yuqing, Wang, Hongtao
Publicado en Medicine (Baltimore) (2018)

MLF1 protein is a potential therapy target for lung adenocarcinoma

por Li, Xiaojun, Min, Shengping, Wang, Hongtao, Shen, Yuanbing, Li, Wei, Chen, Yuqing, Wang, Xiaojing
Publicado en Int J Clin Exp Pathol (2018)

Thermo-responsive polymer encapsulated gold nanorods for single continuous wave laser-induced photodynamic/photothermal tumour therapy

por Gong, Beilei, Shen, Yuanbing, Li, Huiyan, Li, Xiaojun, Huan, Xia, Zhou, Jihong, Chen, Yuqing, Wu, Jian, Li, Wei
Publicado en J Nanobiotechnology (2021)

Nf1 loss promotes Kras‐driven lung adenocarcinoma and results in Psat1‐mediated glutamate dependence

por Wang, Xiaojing, Min, Shengping, Liu, Hongli, Wu, Nan, Liu, Xincheng, Wang, Tao, Li, Wei, Shen, Yuanbing, Wang, Hongtao, Qian, Zhongqing, Xu, Huanbai, Zhao, Chengling, Chen, Yuqing
Publicado en EMBO Mol Med (2019)

The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p

por Wei, Siliang, Zheng, Yuanyuan, Jiang, Yanru, Li, Xiaojun, Geng, Jian, Shen, Yuanbing, Li, Qin, Wang, Xiaojing, Zhao, Chengling, Chen, Yuqing, Qian, Zhongqing, Zhou, Jihong, Li, Wei
Publicado en EBioMedicine (2019)

Chetomin, a Hsp90/HIF1α pathway inhibitor, effectively targets lung cancer stem cells and non-stem cells

por Min, Shengping, Wang, Xiaoxu, Du, Qianyu, Gong, Huiyuan, Yang, Yan, Wang, Tao, Wu, Nan, Liu, Xincheng, Li, Wei, Zhao, Chengling, Shen, Yuanbing, Chen, Yuqing, Wang, Xiaojing
Publicado en Cancer Biol Ther (2020)

A High Percentage of Patients Recovered From COVID-19 but Discharged With Abnormal Liver Function Tests

por Gan, Qinyi, Gong, Beilei, Sun, Manli, Cao, Zhujun, Zheng, Yuyan, Zhang, Yajie, Wen, Pengfei, Shen, Yuanbing, Hong, Lei, Hou, Tingting, Jia, Yuqin, Li, Wei, Li, Hecheng, Xie, Qing
Publicado en Front Physiol (2021)